FDA Investigator Moraima J Ramos Valle
Moraima J Ramos Valle has inspections in 7 countries as of 02 Nov 2023. Moraima J Ramos Valle has collaborated with a combined 1646 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
113
Last Inspection Date:
02 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Costa Rica,
Netherlands,
China,
Japan,
Mexico
Co-Investigator(s):
Adaliz Santaliz Cruz,
Agnes M Santori,
Alonso,
Ana M Rivera,
Annette Melendez,
Arlene M Badillo,
Carlos A Medina,
Carpios,
CDR Ileana Barreto Pettit,
Christos G Tsingelis,
Daryl A Dewoskin,
Dennis L Doupnik,
Dr. Carmelo Rosa,
Dr. Dominick Roselle,
Edward H Maticka,
Edwin Ortega,
Eliezar Ramos,
Enrique Galan,
Eva I Merced Medina,
Frances L Dejesus,
Frank Flores,
Garcial,
German Rivera,
Hector J Colon Torres,
Hector M Fuste,
Holly M Scott,
Iraida Ortiz,
Israel Santiago, OCM,
Ivonne A Vicente,
Jaime E Pares,
Jeffrey G Baravik,
Jennifer A Robinson,
Jennifer Lalama,
Jessica L Pressley,
Jogy George,
John P Shelton,
Jorge E Martinez,
Jorge L Lajara,
Jose Acruz Gonzalez,
Jose E Melendez, DDC,
Jose Fpedrode Jesus,
Jose Perez Soto,
Jose Velez,
Joshua J Silvestri,
Juan Rjimenez Garcia,
Juarbe,
Karissa J Mccaw,
Karl D Hezel,
Katherine Vargas Serrano,
Laiza V Garcia,
Laura E Garcia,
LCDR Michael H Tollon,
Leslie A Mendoza,
Lisa M Lopez,
Lizaida E Rodriguez,
Lourdes Andujar,
LT Kimberly M Hull,
LT Rafael Gonzalez,
Luis A Martinez Larracuente,
Luis M Burgos Medero,
Luis Soto Lopez,
Luz N Riveradecruz,
Lynne Ensor,
Madelyn Renteria,
Maria A Ruttell,
Maribel V Juarbe,
Matthew B Thomaston,
Medina,
Mendoza,
Miguel A Martinez,
Miguel G Manzano,
Miguel Hernandez Sanchez,
Nancy Rosado,
Neisa M Alonso,
Nicole E Knowlton,
Noreen Muniz,
Ormond,
Pablo Feliciano,
Paul L Figarole, Jr,
Ramon A Hernandez,
Raquel Gonzalez Rivera,
Rebecca Rodriguez,
Rosario D'costa,
Saleem A Akhtar,
Salvatore N Randazzo,
Samina S Khan,
Sandra Carpio,
Sixto M Mercado Rios,
Stacey F Allard,
State Agency,
Terri L Dodds,
Vilmary Negron Rodriguez,
Zuleika A Pineiro Vargas
Moraima J Ramos Valle's Documents
Publish Date | Document Type | Title |
---|---|---|
December, 2019 | FDA 483 | E. Franco & Co. Inc - Form 483, 2019-12-19 |
July, 2023 | FDA 483 | Catalent Pharma Solutions, LLC - Form 483, 2023-07-21 |
July, 2015 | FDA 483 | Viatris Pharmaceuticals LLC - Form 483, 2015-07-02 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more